196 related articles for article (PubMed ID: 26641645)
1. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease.
Kim H; Park HC; Ryu H; Kim K; Kim HS; Oh KH; Yu SJ; Chung JW; Cho JY; Kim SH; Cheong HI; Lee K; Park JH; Pei Y; Hwang YH; Ahn C
PLoS One; 2015; 10(12):e0144526. PubMed ID: 26641645
[TBL] [Abstract][Full Text] [Related]
2. Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.
van Aerts RMM; Kievit W; de Jong ME; Ahn C; Bañales JM; Reiterová J; Nevens F; Drenth JPH
Liver Int; 2019 Mar; 39(3):575-582. PubMed ID: 30225933
[TBL] [Abstract][Full Text] [Related]
3. Fatal liver cyst rupture in polycystic liver disease complicated with autosomal dominant polycystic kidney disease: A case report.
Tong F; Liang Y; Zhang L; Li W; Chen P; Duan Y; Zhou Y
Forensic Sci Int; 2016 May; 262():e5-8. PubMed ID: 27050907
[TBL] [Abstract][Full Text] [Related]
4. Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use.
Mizuno H; Sekine A; Suwabe T; Ikuma D; Yamanouchi M; Hasegawa E; Sawa N; Ubara Y; Hoshino J
PLoS One; 2022; 17(2):e0264065. PubMed ID: 35176098
[TBL] [Abstract][Full Text] [Related]
5. Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease.
Misra A; Loyalka P; Alva F
South Med J; 1999 Jun; 92(6):626-7. PubMed ID: 10372860
[TBL] [Abstract][Full Text] [Related]
6. Complex liver cysts in Autosomal Dominant Polycystic Kidney Disease.
Farooq Z; Behzadi AH; Blumenfeld JD; Zhao Y; Prince MR
Clin Imaging; 2017; 46():98-101. PubMed ID: 28768225
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Park HC; Ryu H; Kim YC; Ahn C; Lee KB; Kim YH; Han S; Bae EH; Jeong K; Choi J; Oh KH; Oh YK
J Korean Med Sci; 2023 Sep; 38(38):e296. PubMed ID: 37750370
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease.
Hogan MC; Masyuk T; Bergstralh E; Li B; Kremers WK; Vaughan LE; Ihrke A; Severson AL; Irazabal MV; Glockner J; LaRusso NF; Torres VE
Mayo Clin Proc; 2015 Aug; 90(8):1030-7. PubMed ID: 26166166
[TBL] [Abstract][Full Text] [Related]
9. Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.
Gevers TJ; Inthout J; Caroli A; Ruggenenti P; Hogan MC; Torres VE; Nevens F; Drenth JP
Gastroenterology; 2013 Aug; 145(2):357-65.e1-2. PubMed ID: 23665274
[TBL] [Abstract][Full Text] [Related]
10. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
Cnossen WR; Drenth JP
Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.
D'Agnolo HM; Kievit W; Takkenberg RB; Riaño I; Bujanda L; Neijenhuis MK; Brunenberg EJ; Beuers U; Banales JM; Drenth JP
J Hepatol; 2016 Sep; 65(3):601-7. PubMed ID: 27212247
[TBL] [Abstract][Full Text] [Related]
12. The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
D'Agnolo HMA; Casteleijn NF; Gevers TJG; de Fijter H; van Gastel MDA; Messchendorp AL; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JFM; Zietse R; Gansevoort RT; Drenth JPH
Am J Nephrol; 2017; 46(3):239-248. PubMed ID: 28881341
[TBL] [Abstract][Full Text] [Related]
13. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
[TBL] [Abstract][Full Text] [Related]
14. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
[TBL] [Abstract][Full Text] [Related]
15. Center is an important indicator for choice of invasive therapy in polycystic liver disease.
D'Agnolo HM; Kievit W; van Munster KN; van der Laan JJ; Nevens F; Drenth JP
Transpl Int; 2017 Jan; 30(1):76-82. PubMed ID: 27732751
[TBL] [Abstract][Full Text] [Related]
16. [Polycystic liver disease without autosomal dominant polycystic kidney disease].
Peces R; González P; Venegas JL
Nefrologia; 2003; 23(5):454-8. PubMed ID: 14658173
[TBL] [Abstract][Full Text] [Related]
17. Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease.
Tsuchida Y; Tsubata Y; Nozawa R; Maruyama S; Ikarashi K; Saito N; Morioka T; Kamura T; Shimada H; Narita I
CEN Case Rep; 2024 Feb; 13(1):32-36. PubMed ID: 37162720
[TBL] [Abstract][Full Text] [Related]
18. Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide.
Dekker SEI; Bierau J; Giera M; Blomberg N; Drenth JPH; Mayboroda OA; de Fijter JW; Soonawala D;
Eur J Clin Invest; 2024 Apr; 54(4):e14147. PubMed ID: 38071418
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: prevalence and CT findings.
Itai Y; Ebihara R; Eguchi N; Saida Y; Kurosaki Y; Minami M; Araki T
AJR Am J Roentgenol; 1995 Feb; 164(2):339-42. PubMed ID: 7839965
[TBL] [Abstract][Full Text] [Related]
20. Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.
Kim Y; Bae SK; Cheng T; Tao C; Ge Y; Chapman AB; Torres VE; Yu AS; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT
Phys Med Biol; 2016 Nov; 61(22):7864-7880. PubMed ID: 27779124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
